Pneumonia: Parliament unites to tackle global problem

Comment

Des Turner et al. BMJ. 2008.

. 2008 Feb 2;336(7638):233-4.

doi: 10.1136/bmj.39472.508056.3A.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, Kundi Z, Law P, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Sempertegui F, Simon J, Santosham M, Singhi S, Thea DM, Qazi S; Severe Pneumonia Evaluation Antimicrobial Research Study Group. Asghar R, et al. BMJ. 2008 Jan 12;336(7635):80-4. doi: 10.1136/bmj.39421.435949.BE. Epub 2008 Jan 8. BMJ. 2008. PMID: 18182412 Free PMC article. Clinical Trial.

1. Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, et al, for the SPEAR (Severe Pneumonia Evaluation Antimicrobial Research) Study Group. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ 2008;336:80-4. (12 January.) - PMC - PubMed
1. Bhutta ZA. Managing severe pneumonia in children in developing countries. BMJ 2008;336:57-8. (12 January.) - PMC - PubMed